First Eagle Investment Management
Holding/activity history for Halozyme Therapeutics (HALO)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price |
| 2020 Q4 | 0 | 0 | Sell 100.00% | 0.04 | |
| 2020 Q3 | 483,800 | 0.04 | Reduce 68.12% | 0.09 | $26.28 |
| 2020 Q2 | 1,517,627 | 0.13 | Reduce 4.17% | 0.01 | $26.81 |
| 2020 Q1 | 1,583,675 | 0.10 | Reduce 3.23% | 0.00 | $17.99 |
| 2019 Q4 | 1,636,475 | 0.08 | Reduce 0.06% | 0.00 | $17.73 |
| 2019 Q3 | 1,637,475 | 0.07 | $15.51 |